CNR Institutional Research Information System

REFOSCO, FIORENZO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 3.132
NA - Nord America 1.221
SA - Sud America 617
EU - Europa 478
AF - Africa 54
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 2
Totale 5.510
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 1.360
US - Stati Uniti d'America 1.156
CN - Cina 706
BR - Brasile 497
VN - Vietnam 332
HK - Hong Kong 323
FR - Francia 193
KR - Corea 160
NL - Olanda 65
IN - India 53
GB - Regno Unito 42
JP - Giappone 39
AR - Argentina 38
IT - Italia 38
CA - Canada 31
DE - Germania 30
ID - Indonesia 27
BD - Bangladesh 23
IL - Israele 20
CO - Colombia 18
EC - Ecuador 17
FI - Finlandia 16
MX - Messico 14
IQ - Iraq 13
RU - Federazione Russa 13
PL - Polonia 12
VE - Venezuela 12
TN - Tunisia 11
CL - Cile 9
PE - Perù 9
UZ - Uzbekistan 9
ZA - Sudafrica 9
PH - Filippine 8
PK - Pakistan 8
SA - Arabia Saudita 8
UY - Uruguay 8
ES - Italia 7
GR - Grecia 7
PY - Paraguay 7
UA - Ucraina 7
BE - Belgio 6
EG - Egitto 6
KE - Kenya 6
AE - Emirati Arabi Uniti 5
AZ - Azerbaigian 5
JM - Giamaica 5
MA - Marocco 5
TR - Turchia 5
AT - Austria 4
BG - Bulgaria 4
KG - Kirghizistan 4
KW - Kuwait 4
NZ - Nuova Zelanda 4
CI - Costa d'Avorio 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
ET - Etiopia 3
IE - Irlanda 3
JO - Giordania 3
LV - Lettonia 3
MK - Macedonia 3
MY - Malesia 3
RO - Romania 3
SE - Svezia 3
SN - Senegal 3
AU - Australia 2
BO - Bolivia 2
DK - Danimarca 2
GE - Georgia 2
GT - Guatemala 2
LT - Lituania 2
LU - Lussemburgo 2
LY - Libia 2
NO - Norvegia 2
NP - Nepal 2
SK - Slovacchia (Repubblica Slovacca) 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
AG - Antigua e Barbuda 1
AL - Albania 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BJ - Benin 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BY - Bielorussia 1
BZ - Belize 1
CG - Congo 1
CH - Svizzera 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
GP - Guadalupe 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
ME - Montenegro 1
MM - Myanmar 1
Totale 5.502
Salva come PNG Salva come JPEG
Città #
Singapore 804
Santa Clara 485
Hefei 336
Hong Kong 321
Seoul 159
Lauterbourg 154
San Jose 143
Ho Chi Minh City 105
Beijing 92
Hanoi 84
Ashburn 62
Los Angeles 52
Dallas 39
Guangzhou 38
São Paulo 38
Minamishinagawa 17
Rio de Janeiro 17
Tokyo 16
Haiphong 15
Brasília 14
New York 14
Belo Horizonte 13
Bengaluru 13
Buffalo 13
Da Nang 12
Helsinki 12
Frankfurt am Main 11
London 10
Orem 10
Toronto 10
Biên Hòa 9
Hải Dương 9
Warsaw 9
Can Tho 8
Tashkent 8
Brooklyn 7
City of London 7
Curitiba 7
Lima 7
Phoenix 7
Amsterdam 6
Asunción 6
Brussels 6
Campinas 6
Fortaleza 6
Manaus 6
Montreal 6
New Delhi 6
Shanghai 6
Thái Nguyên 6
Athens 5
Baku 5
Chennai 5
Goiânia 5
Guayaquil 5
Ha Long 5
Montevideo 5
Nairobi 5
Ninh Bình 5
Philadelphia 5
Poços de Caldas 5
Riyadh 5
Salvador 5
Taboão da Serra 5
Uberlândia 5
Bauru 4
Belém 4
Casablanca 4
Contagem 4
Guarulhos 4
Hyderabad 4
Milan 4
Moscow 4
Ottawa 4
Phủ Lý 4
Porto Alegre 4
Quito 4
Recife 4
Abidjan 3
Addis Ababa 3
Amman 3
Apucarana 3
Aracaju 3
Auckland 3
Baghdad 3
Berlin 3
Bishkek 3
Bình Dương 3
Cairo 3
Camaçari 3
Campo Grande 3
Canoas 3
Caxias do Sul 3
Chicago 3
Dakar 3
Dayton 3
Dublin 3
Elk Grove Village 3
Erbil 3
Esteio 3
Totale 3.440
Salva come PNG Salva come JPEG
Nome #
Assessment of the best N3- donors in preparation of [M(N)(PNP)]-based (M=Tc-99m-; Re-188) target-specific radiopharmaceuticals: Comparison among succinic dihydrazide (SDH), N-methyl-S-methyl dithiocarbazate (HDTCZ) and PEGylated N-methyl-S-methyl dithiocarbazate (HO2C-PEG(600)-DTCZ) 78
Voltammetric behaviour of rhenium(I) complexes with phosphine and carbon monoxide ligands in acetonitrile solvent 77
. [Re-188(N)(cys)(PNP)](+/0) mixed ligand compounds as models for target specific agents. 73
Synthesis and characterization of novel 99-technetium(III) phosphine complexes. HPLC characterization and rat biodistribution of the Tc-99m analogs 71
Technetium(V) and rhenium(V) complexes with Schiff-base ligands containing the ONNNO donor atom set. Crystal structure of [N,N?-3-azapentane-1,5-diylbis(salicylideneiminato)(3-)-O,O',N, N',N'']-oxotechnetium(V) 69
SYNTHESES AND STRUCTURAL CHARACTERIZATIONS OF 6-COORDINATE OXO-M(V) COMPLEXES (M=TC, RE) CONTAINING A TETRADENTATE P2N2-PHOSPHINO-AMIDO LIGAND 67
Monooxorhenium(V) complexes with the tridentate Schiff base N-(2-hydroxyphenyl)salicylideneimine 63
New approach to the chemistry of technetium(V) and rhenium(V) phenylimido complexes: novel [M(NPh)PNP]3+ metal fragments (M = Tc, Re; PNP = aminodiphosphine) suitable for the synthesis of stable mixed-ligand compounds 62
Insights into the failure of the potential, neutral myocardial imaging agent TcN-NOET: physicochemical identification of by-products and degradation species 57
Novel TcP3X3 (XS, O) cores in Tc(III) chemistry 52
Synthesis, in vitro and in vivo evaluation of new 99mTc-labeled cyclic RGDfK peptide monocationic complexes 51
Melanoma targeting with [Tc-99m(N)(PNP3)]-labeled alpha-melanocyte stimulating hormone peptide analogs: Effects of cyclization on the radiopharmaceutical properties 50
Synthesis and biological evaluation of new [99mTc(N)(PNPn)]2+-labeled cRGDfK peptide: preliminary studies. 50
Synthesis and biological evaluation of new [Tc-99m(III)( PS)(2)(L)] mixed-ligand compounds (PS= phosphino-thiolate; L=dithiocarbamate), useful in design and development of Tc(III)radiopharmaceuticals 50
The crucial role of the diphosphine heteroatom X in the stereochemistry and stabilization of the substitution-inert [M(N)(PXP)]2+ metal fragments (M = Tc, Re; PXP = diphosphine ligand) 49
Synthesis and characterization of rhenium(III) complexes with (Ph2PCH2CH2)(2)NR diphosphinoamine ligands 49
Neutral and charged phosphine/scorpionate copper(I) complexes: Effects of ligand assembly on their antiproliferative activity 49
Copper(I) heteroleptic 3+1 complexes: ligand effect on their in vitro cytotoxicity 48
Studies of new [Tc(N)(PS)]-based mixed compounds as analogues of WAY 100635. 48
Tc-III-based mixed complexes for the design and the development of new SPECT tracers 48
[Tc-99m(N)PNP]-moiety: a suitable scaffold for the developmant of radiolabeled probes for SPECT of multidrug resistance. In vitro study 48
Uncommon Anionic Dioxorhenium(V) and Neutral Monooxorhenium(V) Mixed-Ligand Complexes Containing Heterofunctionalized Phosphine Ligands: Syntheses and Structural Characterization 47
Transglutaminase-mediated conjugation and nitride-technetium-99m labelling of a bis(thiosemicarbazone) bifunctional chelator 47
Synthesis and characterization of novel hexacoordinated, asymmetrical M(III) (M = Re, 99gTc) complexes as models for the development of potential tracers for SPECT imaging and radiotherapy 46
Synthesis, in vitro and in vivo evaluation of new 99mTc-labeled cyclic RGDfK peptide monocationic complexes 46
Synthesis and biological evaluation of new [Tc(N)(PS)]-based mixed-ligand compounds useful in the design of target-specific radiopharmaceuticals: the 2-methoxyphenylpiperazine dithiocarbamate derivatives as an example. 45
Synthesis and characterization of novel asymmetrical M(III) (M = Re, Tc-99g) complexes as models for the development of new potential tracers for SPECT imaging and radiotherapy 44
Radioactive Transition Metal Nitride Hetero-Complex 44
Reactivity of the [M(PS)2](+) Building Block (M = Re(III) and (99m)Tc(III); PS = Phosphinothiolate) toward Isopropylxanthate and Pyridine-2-thiolate. 44
Novel [Tc-99m(III)(PS)(2)(Ln)] Mixed-Ligand Compounds (PS = Phosphinothiolate; L = Dithiocarbamate) Useful in Design and Development of Tc-III-Based Agents: Synthesis, in Vitro, and ex Vivo Biodistribution Studies 43
Electrospray mass spectrometry, mixed nitrido-Tc heterocomplexes and nuclear medicine 42
Phosphanyl-amino complexes of nickel(II): Synthesis and structure 42
Cytotoxicity in human cancer cells and mitochondrial dysfunction induced by a series of new copper(I) complexes containing tris(2-cyanoethyl)phosphines 42
Melanoma targeting with [(TcN)-Tc-99m(PNP3)]-labeled alpha-MSH peptide analogs: Preliminary studies 42
Synthesis and structural characterization of copper(I) complexes bearing N-methyl-1,3,5-triaza-7-phosphaadamantane (mPTA): Cytotoxic activity evaluation of a series of water soluble Cu(I) derivatives containing PTA, PTAH and mPTA ligands 41
Chelating Systems for Tc-99m/Re-188 in the Development of Radiolabeled Peptide Pharmaceuticals 41
[MI(HB(pz)3)(P)] complexes (P = monodentate phosphine): comparison of the antiproliferative activity of silver and copper "3+1" mixed-ligand compounds 41
Synthesis and characterization of novel tetrahedral copper(I) complexes comprising tridentate PNP-aminodiphosphines and tetradentate PN(X)P-substituted aminodiphosphines (X = O, S) 41
Polydentate phosphinoamine ligands: a class of efficient chelating agents for the stabilization of various technetium(V) and rhenium(V) cores 40
Synthesis and characterization of novel asymmetrical M(III) (M = Re, 99gTc) complexes as models for the development of potential tracers for SPECT imaging and radiotherapy. 40
Insights into the failure of the potential, neutral myocardial imaging agent TcN-NOET : physico-chemical identification of by-products and degradation species 40
Synthesis and characterization of technetium(V) oxo-complexes with quadridentate Schiff-base ligands: X-ray structures of ?-oxo-bis-{oxo[N,N?-propane-1,3-diylbis(salicylideneiminato)] technetium(V)} and chloro-oxo[N,N?-propane-1,3-diylbis(salicylideneiminato)]-technetium(V) 39
Synthesis and Characterization of [MIII(PS)2(L)] mixed-ligand compounds (M = Re, 99Tc; PS= phosphino-thiolate; L= dithiocarbamate) as a model for the Development of New Agents for SPECT Imaging and Radiotherapy 38
[188Re(N)(Cys~)(PNP)]+/0 mixed ligand compounds as models for the development of target specific agents 38
Synthesis, characterization, and biological evaluation of neutral nitrido technetium(V) mixed ligand complexes containing dithiolates and aminodiphosphines. A novel system for linking technetium to biomolecules 37
Synthesis, Characterization and Crystal Structure of the Water Soluble Copper(I) Complex with Trisulfonated Triphenylphosphine 37
Contribution of electrospray mass spectrometry for the characterization, design, and development of nitrido technetium and rhenium heterocomplexes as potential radiopharmaceuticals 37
Synthesis and biological evaluation of [188Re(N)(CYS~)(PNP)]+/0 complexes as prototypes for the development of [188Re(N)(PNP)-based target vectors 36
Synthesis and characterization of a new series of asymmetrical M(III) (M = Re, 99gTc) complexes of the type [MIII(PS)2(L)], where PS = phosphinothiolate; L = dithiocarbamate (DTCn) or pyridine-2-thiolate (MPy) - Synthesis and characterization of novel asy 36
Synthesis, characterization and biological evaluation of [(188)Re(N)(cys similar to)(PNP)](+/0) mixed-ligand complexes as prototypes for the development of (188)Re(N)-based target-specific radiopharmaceuticals 36
Low-Valent Technetium Complexes with Aminodiphosphines 35
The [Tc(N)PNP] Metal Fragment Labeled Peptide for MC1 Receptors Imaging: preliminary studies 34
Co-ordination of (o-aminophenyl)diphenylphosphine in complexes containing the [Mv = O]3+ (M = Tc or Re) core 34
A NEW PHASE OF BIS[2-(DIPHENYLPHOSPHINO-K-P-PHENYLAZANIDO-K-N](ETHANOLATO)(OXO)-RHENIUM(V) 34
Synthesis and Characterization of Novel Asymmetrical M(III) (M = Re, 99gTc) Complexes as Models for the Development of Potential Tracers for SPECT Imaging and Radiotherapy 33
A New series of [99mTc(N)(DTC)(PNP)]+ complexes as potential myocardial imaging agents 33
The [99mTc(N)(PNP)]2+ Metal Fragment : A Technetium-Nitrido Synthon for use with Biologically Active Molecules. The N-(2-Methoxyphenyl)piperazyl-cysteine Analogues as Examples. 33
Synthesis and characterization of novel asymmetrical M(III) (M = Re, 99gTc) complexes as models for the development of potential tracers for SPECT imagin and radiotherapy 33
The (Tc(N)(PNP))(2+) metal fragment labeled cholecystokinin-8 (CCK8) peptide for CCK-2 receptors imaging: in vitro and in vivo studies 33
99mTc-Radiolabeled Peptides for Tumour Imaging: Present and Future 33
Synthesis of a novel class of trigonal bipyramidal nitrido Tc(V) complexes with phosphino-thiol ligands. Crystal structure of [Tc-99g(N)(L-1)(2)] [L-1=2-(diphenylphosphino)ethanethiolato] and [Tc-99g(N)(L-5)(2)] [L5=2-(ditolylphosphino)propanethiolato] 32
Mixed-Ligand Rhenium-188 Complexes with Tetradentate/Monodentate NS3/P ('4 + 1') Coordination: Relation of Structure with Antioxidation Stability 32
Tc and Re Nitrido Asymmetrical Heterocomplexes. A '2+2' Approach 32
Reactivity of Bi- and Tetra-Dentate Phosphinoamine Ligands Toward Technetium and Rhenium 31
Trigonal-Bypyramidal Tc(V) and Tc(III) Complexes with Mixed S,P-Bidentate Phosphine-Thiols 30
Complessi azoturo dissimmetrici monocationici di metalli di transizione radioattivi 30
Syntheses and reactivity of sulphur rich Re(III) and Tc(III) complexes containing trithioperoxybenzoate, dithiobenzoate and dithiocarbamate ligands 30
Synthetic routes to mono-N-functionalized P2N2-ligands 30
Syntheses and characterization of amino and amido-imido technetium(V) and rhenium(V) complexes with (o-aminophenyl)diphenylphosphine-N,P. Crystal structures of [TcNCl{PPh2(C6H4NH2-2)} 2]Cl·MeCN and [Re{PPh2(C6H4N-2)}Cl2{PPh 2(C6H4NH-2}] 30
Alternative Synthesis of Aminodiphosphines 30
. [Re-188(N)(cys)(PNP)](+/0) mixed ligand compounds as models for target specific agents. 29
Technetium coordination chemistry; development of new backbones for 99mTc radiopharmaceuticals 29
A mass spectrometric investigation of a series of [ReOX(PY)(2)] complexes containing bidentate phosphinophenolate and phosphinoamine ligands 29
The metal-fragment strategy for the construction of stable Tc and Re mixed-ligand compounds relevant to nuclear medicine 29
ESI/MSn in the structural characterisation of some nitrido-Re heterocomplexes 29
Synthesis and Characterization of Novel Asymmetrical M(III) (M = Re, 99gTc) Complexes as Models for the Development of Potential Tracers for SPECT Imaging and Radiotherapy 29
Synthesis and characterization of nitrido Tc(V) and Re(V) complexes with ferrocenedithiocarboxylate {FcCS(2)=[Fe(C5H4CS2)(C5H5)](-)} 29
Synthesis and characterization of [dichloro[hydrotris(1-pyrazolyl)borate]sulfido-technetium(V)] and [bis-(u-ethane-1,2-dithiolato)-bis-(ethene-1,2-dithiolato)-technetium(IV)] complexes. The first evidence of a terminal Tc=S multiple bond 28
SYNTHESIS AND CHARACTERIZATION OF TECHNETIUM(V) AND RHENIUM(V) OXO-COMPLEXES WITH SCHIFF-BASE LIGANDS CONTAINING THE ONN DONOR-ATOM SET - MOLECULAR-STRUCTURE OF TRANS-DICHLORO-OXO[1-(8'-QUINOLYLIMINOMETHYL)-2-NAPHTHOLATO-NN'O]TECHNETIUM(V) 28
The [Tc(N)PNP]2+ metal fragment labeled Cholecystokinin-8 (CCK8) peptide for CCK2 receptors imaging: preliminary biological studies 28
The relationship between the electrospray ionization behaviour and biological activity of some phosphino Cu(I) complexes 28
Synthesis, solution-state and solid-state structural characterization of monocationic nitrido heterocomplexes [M(N)(DTC(PNP)](+) (M=Tc-99, Re; DTC = dithiocarbamate; PNP=heterodiphosphane) 28
Synthesis of a series of Cu(I) derivatives containing PTA, PTAH and mPTA ligands and evaluation of their cytotoxic activity 28
Neutral and cationic nickel (II) complexes of phosphino-amines: [NiCl2(PMe2Ph)(PNMe2)] and [NiCl(PMe2Ph) (PNMe2)]PF6 (PNMe2 = N,N?-dimethyl-2-(diphenylphosphino) aniline) 27
Mixed ligand Tc-and Re-nitrido complexes for radiolabelling bioactive molecules 27
Biological in vitro and in vivo studies of a series of new asymmetrical cationic [99mTc(N)(DTC-Ln)(PNP)]+ complex (DTC-Ln = alicyclic dithiocarbamate, PNP = bisphosphinoamine). 27
Cytotoxicity in human cancer cells and mitochondrial dysfunction induced by a series of new copper(I) complexes containing tris(2-cyanoethyl)phosphines 27
99mTc-nitrido complexes with a library of cysteine-biotin derivatives for pretargeting avidin-biotin immunoscintigraphy 27
[Tc-99m(N)(DBODC)(5)]+: sub-cellular distribution and metabolism studies of this new potential myocardial imaging agent 27
Cytotoxicity and mitochondrial disfunction induced by copper(I) complexes with tris(cyanoethyl)phosphine or tris(carboxyethyl)phosphine 26
SYNTHESIS AND CHARACTERIZATION OF NEUTRAL TECHNETIUM(III) COMPLEXES WITH MIXED S,P-BIDENTATE PHOSPHINE THIOLATE LIGANDS - CRYSTAL-STRUCTURE OF [TC(SCH2CH2PPH2)2(SCH2CH2PPH2O)] 26
Synthesis of a novel class of nitrido Tc-99m radiopharmaceuticals with phosphino-thiol ligands showing transient heart uptake 26
A library of cysteine-biotine derivatives useful for pretargeting avidin-biotin radioimmunoscintigraphy 26
Design and Synthesis Of Tc- And Re-Based Metal-Fragments 26
UNUSUAL SYNTHESIS AND X-RAY STRUCTURE OF CIS-DICHLORO[1,2-BIS(O-(DIPHENYLPHOSPHINO)PHENYL)ETHANE-1,2-DIOLATO(2-)]TECHNETIUM(IV) HEMIETHANOL SOLVATE 26
Synthesis and biodistribution in rats of a nitridotechnetium-99m radiopharmaceutical incorporating a benzodiazepine-receptor-specific ligand 26
Synthesis, in vitro and in vivo characterization of 64Cu(I) complexes derived from hydrophilic tris(hydroxymethyl)phosphane and 1,3,5-triaza-7-phosphaadamantane ligands 26
Synthesis of Asymmetrical Heterocomplexes of the [99mTc/99gTc(N)(PNP)]2+ Fragment with Cysteine-Functionalized Biotin 25
Crystal structures of neutral trigonal bipyramidal [NiCl2(PMePh2)(PNMe2)]center dot 1/2CH(2)Cl(2) and cationic square planar [NiCl(PMePh2)(PNMe2)][PF6] complexes 25
Copper(I) and copper(II) complexes of polydentate phosphinoamines 25
Totale 3.859
Salva come PNG Salva come JPEG
Categoria #
all - tutte 20.947
article - articoli 12.894
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 257
Totale 34.098
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202457 0 0 0 0 0 0 0 0 2 0 53 2
2024/20252.149 16 12 184 93 418 94 20 86 25 59 599 543
2025/20263.304 200 331 392 599 578 130 511 175 151 176 61 0
Totale 5.510